$GDRZF
GOLD RESERVE LTD Stock $gdrzf

$gdrzf Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000107272523000009 Filed on April 27, 2023

Income Statement

Concept	2022 Q4	2022
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$104.1K
YoY Change		-2.15%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$466.7K
YoY Change		413.4%
Pretax Income		-$8.597M
YoY Change		-18.88%
Income Tax
% Of Pretax Income
Net Earnings		-$8.597M
YoY Change		-18.88%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	99.55M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.48M	$49.22M
YoY Change	-68.55%
Cash & Equivalents	$15.38M	$49.12M
Short-Term Investments	$98.05K	$105.2K
Other Short-Term Assets	$458.9K	$506.7K
YoY Change	-9.42%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$51.53M	$58.41M
YoY Change	-11.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.416M	$2.154M
YoY Change	-34.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.416M	$2.228M
YoY Change	-36.44%
TOTAL ASSETS
Total Short-Term Assets	$51.53M	$58.41M
Total Long-Term Assets	$1.416M	$2.228M
Total Assets	$52.94M	$60.64M
YoY Change	-12.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.351M	$610.6K
YoY Change	121.33%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.351M	$610.6K
Total Long-Term Liabilities
Total Liabilities	$1.351M	$610.6K
YoY Change	121.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$295.3M	-$286.7M
YoY Change	3.0%
Common Stock	$323.3M	$323.3M
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$51.59M	$60.03M
YoY Change
Total Liabilities & Shareholders Equity	$52.94M	$60.64M
YoY Change	-12.69%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income		-$8.597M
YoY Change		-18.88%
Depreciation, Depletion And Amortization		$104.1K
YoY Change		-2.15%
Cash From Operating Activities		-$6.363M
YoY Change		-26.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$27.37M
YoY Change		-8845.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities		-$6.363M
Cash From Investing Activities		-$27.37M
Cash From Financing Activities
Net Change In Cash		-$33.74M
YoY Change		306.58%
FREE CASH FLOW
Cash From Operating Activities		-$6.363M
Capital Expenditures
Free Cash Flow		-$6.363M
YoY Change		-26.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001072725
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Entity Registrant Name EntityRegistrantName	GOLD RESERVE INC.
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A0
CY2021Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	gdrzf	Severanceaccrual Severanceaccrual		usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2021	gdrzf	Contingent Value Rights ContingentValueRights		usd
CY2021	gdrzf	Writedown Of Ppe WritedownOfPPE		usd
CY2022	gdrzf	Loss On Impairment Of Bank Account LossOnImpairmentOfBankAccount		usd
CY2020	gdrzf	Loss On Impairment Of Bank Account LossOnImpairmentOfBankAccount		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	gdrzf	Writedown Of Property Plant And Equipment WritedownOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	gdrzf	Amortization Discount Term Deposits AmortizationDiscountTermDeposits		usd
CY2020	gdrzf	Amortization Discount Term Deposits AmortizationDiscountTermDeposits		usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable		usd
CY2021	gdrzf	Increase Decrease Severance Accrual IncreaseDecreaseSeveranceAccrual		usd
CY2020	gdrzf	Increase Decrease Severance Accrual IncreaseDecreaseSeveranceAccrual		usd
CY2021	gdrzf	Increase Decrease Cvr Accrual IncreaseDecreaseCVRAccrual		usd
CY2020	gdrzf	Increase Decrease Cvr Accrual IncreaseDecreaseCVRAccrual		usd
CY2021	gdrzf	Purchase Time Deposits PurchaseTimeDeposits		usd
CY2020	gdrzf	Purchase Time Deposits PurchaseTimeDeposits		usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021Q4	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-31819
CY2022	dei	Entity Registrant Name EntityRegistrantName	GOLD RESERVE INC.
CY2022	dei	Entity Address Country EntityAddressCountry	CA
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	999 West Riverside Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 401
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Spokane
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	99201
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	99547710	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2022	dei	Auditor Firm AuditorFirmId	271
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15380489	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49117630	usd
CY2022Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	27499188	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	98053	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	105218	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	8091104	usd
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	8682839	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	458939	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	506663	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	51527773	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	58412350	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1416152	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2153678	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74415	usd
CY2022Q4	us-gaap	Assets Assets	52943925	usd
CY2021Q4	us-gaap	Assets Assets	60640443	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	647283	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	473226	usd
CY2022Q4	gdrzf	Severanceaccrual Severanceaccrual	531981	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	77093	usd
CY2022Q4	gdrzf	Accrued Contingent Value Rights AccruedContingentValueRights	172077	usd
CY2021Q4	gdrzf	Accrued Contingent Value Rights AccruedContingentValueRights	60242	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1351341	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	610561	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1351341	usd
CY2021Q4	us-gaap	Liabilities Liabilities	610561	usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	302679682	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	302679682	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99547710	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99547710	shares
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20625372	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20625372	usd
CY2022Q4	gdrzf	Accumulated Stock Option Expense AccumulatedStockOptionExpense	23561301	usd
CY2021Q4	gdrzf	Accumulated Stock Option Expense AccumulatedStockOptionExpense	23402083	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-295273771	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-286677255	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	51592584	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	60029882	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52943925	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60640443	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	582523	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	31095	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	294277	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-8410	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	58562	usd
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-30476	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7165	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	21643	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	5756	usd
CY2022	gdrzf	Foreign Currency Gain Loss ForeignCurrencyGainLoss	-100275	usd
CY2021	gdrzf	Foreign Currency Gain Loss ForeignCurrencyGainLoss	-20402	usd
CY2020	gdrzf	Foreign Currency Gain Loss ForeignCurrencyGainLoss	24100	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	466673	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	90898	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	293657	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5149650	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6018724	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5147333	usd
CY2022	gdrzf	Contingent Value Rights ContingentValueRights	461835	usd
CY2020	gdrzf	Contingent Value Rights ContingentValueRights	59549	usd
CY2022	gdrzf	Siembra Minera Project Costs SiembraMineraProjectCosts	223237	usd
CY2021	gdrzf	Siembra Minera Project Costs SiembraMineraProjectCosts	1675469	usd
CY2020	gdrzf	Siembra Minera Project Costs SiembraMineraProjectCosts	1568741	usd
CY2022	gdrzf	Writedown Of Ppe WritedownOfPPE	622969	usd
CY2020	gdrzf	Writedown Of Ppe WritedownOfPPE	3749531	usd
CY2021	gdrzf	Loss On Impairment Of Bank Account LossOnImpairmentOfBankAccount	1166529	usd
CY2022	us-gaap	Exploration Expense ExplorationExpense	62096	usd
CY2021	us-gaap	Exploration Expense ExplorationExpense	118259	usd
CY2020	us-gaap	Exploration Expense ExplorationExpense	73683	usd
CY2022	gdrzf	Legal And Accounting LegalAndAccounting	1924808	usd
CY2021	gdrzf	Legal And Accounting LegalAndAccounting	1245721	usd
CY2020	gdrzf	Legal And Accounting LegalAndAccounting	698810	usd
CY2022	gdrzf	Arbitration And Settlement ArbitrationAndSettlement	450477	usd
CY2021	gdrzf	Arbitration And Settlement ArbitrationAndSettlement	145147	usd
CY2020	gdrzf	Arbitration And Settlement ArbitrationAndSettlement	1132291	usd
CY2022	gdrzf	Equipment Holding Costs EquipmentHoldingCosts	168117	usd
CY2021	gdrzf	Equipment Holding Costs EquipmentHoldingCosts	317841	usd
CY2020	gdrzf	Equipment Holding Costs EquipmentHoldingCosts	470364	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9063189	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10687690	usd
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	12900302	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8596516	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10596792	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12606645	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1089360	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8596516	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10596792	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-11517285	usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.09
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.11
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.12
CY2022	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	99547710	shares
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	99481626	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	99395048	shares
CY2021	gdrzf	Shares Issued Retirement Plan SharesIssuedRetirementPlan	152662	shares
CY2022	us-gaap	Profit Loss ProfitLoss	-8596516	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-10596792	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-11517285	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	159218	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1992415	usd
CY2020	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	656775	usd
CY2022	us-gaap	Depreciation Depreciation	104143	usd
CY2021	us-gaap	Depreciation Depreciation	106428	usd
CY2020	us-gaap	Depreciation Depreciation	124267	usd
CY2022	gdrzf	Writedown Of Property Plant And Equipment WritedownOfPropertyPlantAndEquipment	622969	usd
CY2020	gdrzf	Writedown Of Property Plant And Equipment WritedownOfPropertyPlantAndEquipment	3749531	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	8410	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-58562	usd
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	30476	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	7165	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-21643	usd
CY2020	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-5756	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1089360	usd
CY2022	gdrzf	Amortization Discount Term Deposits AmortizationDiscountTermDeposits	-122627	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	591735	usd
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3204812	usd
CY2022	gdrzf	Increase Decrease Severance Accrual IncreaseDecreaseSeveranceAccrual	531981	usd
CY2022	gdrzf	Increase Decrease Cvr Accrual IncreaseDecreaseCVRAccrual	111835	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	47724	usd
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	66748	usd
CY2020	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	174461	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	171379	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-99322	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	113270	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6362584	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8610728	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4558809	usd
CY2022	gdrzf	Purchase Time Deposits PurchaseTimeDeposits	-27376561	usd
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	100126	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2004	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	315389	usd
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	98649	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2381	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46753	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27374557	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	313008	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	152022	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33737141	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8297720	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4406787	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49117630	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57415350	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61822137	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15380489	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49117630	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57415350	usd
CY2021Q4	gdrzf	Siembra Minera Beneficial Ownership By Venezuela SiembraMineraBeneficialOwnershipByVenezuela	0.55	pure
CY2021Q4	gdrzf	Siembra Minera Beneficial Ownership By Company SiembraMineraBeneficialOwnershipByCompany	0.45	pure
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zu3dmfDFjP9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><b><i><span id="xdx_862_zq1dKILkjfhb">Use of Estimates</span></i></b>. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	105218	usd
CY2019Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	83575	usd
CY2021	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-7165	usd
CY2020	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	21643	usd
CY2021Q4	gdrzf	Total Award TotalAward	740300000	usd
CY2021Q4	gdrzf	Settlement Agreement SettlementAgreement	1032000000.000	usd
CY2021Q4	gdrzf	Venezuela Agreed To Pay For Award VenezuelaAgreedToPayForAward	792000000	usd
CY2021Q4	gdrzf	Venezuela Agreed To Pay For Mining Data VenezuelaAgreedToPayForMiningData	240000000	usd
CY2021Q4	gdrzf	Payments Made Pursuant To Settlement Agreement PaymentsMadePursuantToSettlementAgreement	254000000	usd
CY2021Q4	gdrzf	Amount Due And Unpaid Including Interest AmountDueAndUnpaidIncludingInterest	972000000	usd
CY2021Q4	gdrzf	Interest Due InterestDue	194000000	usd
CY2021Q4	gdrzf	Amount Of Proceeds Cvr Holders Entitled To AmountOfProceedsCvrHoldersEntitledTo	0.05466	pure
CY2021Q4	gdrzf	Cumulative Amount Paid To Cvr Holders CumulativeAmountPaidToCvrHolders	10000000	usd
CY2022Q4	gdrzf	Increase In Obligation To Cvr Holders IncreaseInObligationToCvrHolders	60000	usd
CY2022Q4	gdrzf	Share Ownership Steelhead ShareOwnershipSteelhead	10.1	pure
CY2022Q4	gdrzf	Cvr Settlement Steelhead CVRSettlementSteelhead	350000	usd
CY2022Q4	gdrzf	Cvr Settlement Others CVRSettlementOthers	112000	usd
CY2022Q4	gdrzf	Cvr Settlement Greywolf CVRSettlementGreywolf	85000	usd
CY2022Q4	gdrzf	Share Ownership Greywolf ShareOwnershipGreywolf	14.8	pure
CY2022	gdrzf	Cvr Expense2022 CVRExpense2022	462000	usd
CY2022Q4	gdrzf	Cvr Payable CVRPayable	112000	usd
CY2022Q4	gdrzf	Bonus Percentage Of First Two Hundred Million Collected BonusPercentageOfFirstTwoHundredMillionCollected	0.0128	pure
CY2022Q4	gdrzf	Bonus Percentage Thereafter BonusPercentageThereafter	0.064	pure
CY2022Q4	gdrzf	Cumulative Amount Paid To Bonus Plan Participants CumulativeAmountPaidToBonusPlanParticipants	4400000	usd
CY2022Q4	gdrzf	Increase In Obligation To Bonus Plan Participants IncreaseInObligationToBonusPlanParticipants	70000	usd
CY2021Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	98053	usd
CY2020Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	105218	usd
CY2022	gdrzf	Impairment Writedown ImpairmentWritedown	600000	usd
CY2020	gdrzf	Impairment Writedown ImpairmentWritedown	3700000	usd
CY2022	gdrzf	Gain On Disposition Of Equipment GainOnDispositionOfEquipment	-8410	usd
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	1123095	usd
CY2021Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	1846842	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	14257394	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	47270788	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15380489	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49117630	usd
CY2021	gdrzf	Bank Account Impairment BankAccountImpairment	1166529	usd
CY2022	gdrzf	Term Deposits TermDeposits	<p id="xdx_808_ecustom--TermDeposits_zzmizUlmouP" style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><b>Note 4. <span id="xdx_825_zbUBdlVYTIc4">Term Deposits:</span></b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 47%; line-height: 12pt"> </td> <td style="width: 1%; text-align: right"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 2%; text-align: right"> </td> <td style="width: 3%; text-align: right"> </td> <td style="width: 3%; text-align: right"> </td> <td id="xdx_49D_20221231_zfpjgpvRIvId" style="width: 15%; text-align: center"><span style="font-size: 10pt">December 31,</span></td> <td style="width: 2%; text-align: right"> </td> <td id="xdx_49A_20211231_zOmrOs1ubq23" style="width: 16%; text-align: center"><span style="font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: top"> <td style="line-height: 12pt"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">2022</span></td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt">2021</span></td></tr> <tr id="xdx_40A_eus-gaap--USGovernmentSecuritiesAtCarryingValue_iI_zKpN1PRlG9Ok"> <td style="border-bottom: Black 1pt solid; vertical-align: top; line-height: 12pt"><span style="font-size: 10pt">U.S. Treasury Bills</span></td> <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 4.7pt; text-align: right"><span style="font-size: 10pt">27,499,188</span></td> <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 4.7pt; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0479">–</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: justify; text-indent: 0.75in">The Company has term deposits which are classified as held to maturity, carried at amortized cost and have original maturities of between 3 and 12 months. Term deposits consist of U.S. treasury bills purchased at a discount and amortized to face value over their respective terms. In 2022, the Company recorded non-cash interest income of <span id="xdx_90C_ecustom--NonCashInterestIncome_c20220101__20221231_zeUTzG0f7bHl">$122,627</span> related to the amortization of discount on term deposits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 6pt; text-align: justify"> </p>
CY2022Q4	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	27499188	usd
CY2022	gdrzf	Non Cash Interest Income NonCashInterestIncome	122627	usd
CY2021	gdrzf	Gain On Disposition Of Equipment GainOnDispositionOfEquipment	58562	usd
CY2020	gdrzf	Gain On Disposition Of Equipment GainOnDispositionOfEquipment	-30476	usd
CY2022Q1	gdrzf	Siembra Minera Costs To Date SiembraMineraCostsToDate	22900000	usd
CY2022Q4	gdrzf	Costs Previously Classified As Siembra Minera CostsPreviouslyClassifiedAsSiembraMinera	700000	usd
CY2022	gdrzf	Cash Contributions To The Plan CashContributionsToThePlan	140000	usd
CY2021	gdrzf	Cash Contributions To The Plan CashContributionsToThePlan	163000	usd
CY2020	gdrzf	Share Value Ksop Contribution ShareValueKSOPContribution	170000	usd
CY2021Q4	gdrzf	Maximum Number Of Options Available Under The Plan MaximumNumberOfOptionsAvailableUnderThePlan	9939500	shares
CY2021Q4	gdrzf	Options Available For Grant OptionsAvailableForGrant	2361107	shares
CY2022	gdrzf	Stock Option Transactions StockOptionTransactions	<table cellpadding="0" cellspacing="0" id="xdx_881_ecustom--StockOptionTransactions_zc5qZknQewuc" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock Option Transactions (Details)"> <tr> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2022</span></td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2021</span></td> <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2020</span></td></tr> <tr> <td style="vertical-align: bottom; width: 36%; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Shares</span></td> <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Weighted Average Exercise Price</span></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Shares</span></td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Weighted Average Exercise Price</span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Shares</span></td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 11%; padding-right: -0.05in; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Weighted Average Exercise Price</span></td> <td style="width: 1%"> </td></tr> <tr> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt"><span style="font-size: 8pt">Options outstanding - beginning of period</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zxdfShe0Byjg" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">7,218,393</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjDeTyH3uh74" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">$ 2.08</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zdT8oCAiKhOh" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">4,629,565</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzuQzmXliDId" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">$ 2.36</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_za8SCtvJIYie" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">4,369,565</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ze4sp3BCH2Zk" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">$ 3.09</span></td> <td> </td></tr> <tr> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt"><span style="font-size: 8pt">Options granted</span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_z6zj0ycUM4Gg" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">360,000</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zLRU61Oqpyri" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"> 1.07</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_zw53VNghIHSj" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"> 3,033,750</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_z6PZXbCHyXxl" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"> 1.60</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20200101__20201231_z9rl56Igu7L9" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">260,000</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_zRqVtUeUfB7d" style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">1.72</span></td> <td> </td></tr> <tr> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt"><span style="font-size: 8pt">Options expired</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231_zI6ZfjOtRVzc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_z24uL8WhLlhj" style="padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20210101__20211231_zwEAPnqtfXV9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">(444,922)</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zujAzkATFZy9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">1.85</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c20200101__20201231_zzHnh3wVUVL1" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231_zrJvvCzAiN39" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0571">-</span></span></td> <td> </td></tr> <tr> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt"><span style="font-size: 8pt">Options outstanding - end of period</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXGnPDeeVv88" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">7,578,393</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6xH1nkJSrLf" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">$ 2.03</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQKbVJ4lJsvg" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">7,218,393</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGx73MAPxjFl" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">$ 2.08</span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWkS3l9C8Yvf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">4,629,565</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zY75fTvVfTMh" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"><span style="font-size: 8pt">$ 2.36</span></td> <td> </td></tr> <tr> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt"> </td> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"> </td> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"> </td> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"> </td> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"> </td> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"> </td> <td style="vertical-align: top; padding-right: -0.05in; padding-left: 5.4pt; text-align: right"> </td> <td> </td></tr> </table>
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	360000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3033750	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.60
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	260000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.72
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	444922	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.85
CY2022Q4	gdrzf	Outstanding Options Number99 To128 OutstandingOptionsNumber99To128	360000	shares
CY2022Q4	gdrzf	Outstanding Options Aggregate Intrinsic Value99 To128 OutstandingOptionsAggregateIntrinsicValue99To128	73250	usd
CY2022	gdrzf	Outstanding Options Weighted Average Remaining Contractual Term Years99 To128 OutstandingOptionsWeightedAverageRemainingContractualTermYears99To128	P9Y10M2D
CY2022Q4	gdrzf	Exercisable Options Number99 To128 ExercisableOptionsNumber99To128	360000	shares
CY2022Q4	gdrzf	Exercisable Options Weighted Average Exercise Price99 To128 ExercisableOptionsWeightedAverageExercisePrice99To128	1.07
CY2022Q4	gdrzf	Exercisable Options Aggregate Intrinsic Value99 To128 ExercisableOptionsAggregateIntrinsicValue99To128	73250	usd
CY2022	gdrzf	Exercisable Options Weighted Average Remaining Contractual Term Years99 To128 ExercisableOptionsWeightedAverageRemainingContractualTermYears99To128	P9Y10M2D
CY2021Q4	gdrzf	Outstanding Options Number160 To160 OutstandingOptionsNumber160To160	2983750	shares
CY2022Q4	gdrzf	Outstanding Options Aggregate Intrinsic Value160 To160 OutstandingOptionsAggregateIntrinsicValue160To160	0	usd
CY2022	gdrzf	Outstanding Options Weighted Average Remaining Contractual Term Years160 To160 OutstandingOptionsWeightedAverageRemainingContractualTermYears160To160	P8Y9M3D
CY2022Q4	gdrzf	Exercisable Options Number160 To160 ExercisableOptionsNumber160To160	2983750	shares
CY2022Q4	gdrzf	Exercisable Options Weighted Average Exercise Price160 To160 ExercisableOptionsWeightedAverageExercisePrice160To160	1.60
CY2022Q4	gdrzf	Exercisable Options Aggregate Intrinsic Value160 To160 ExercisableOptionsAggregateIntrinsicValue160To160	0	usd
CY2022	gdrzf	Exercisable Options Weighted Average Remaining Contractual Term Years160 To160 ExercisableOptionsWeightedAverageRemainingContractualTermYears160To160	P8Y9M3D
CY2022Q4	gdrzf	Outstanding Options Number161 To193 OutstandingOptionsNumber161To193	435000	shares
CY2022Q4	gdrzf	Outstanding Options Aggregate Intrinsic Value161 To193 OutstandingOptionsAggregateIntrinsicValue161To193	0	usd
CY2022	gdrzf	Outstanding Options Weighted Average Remaining Contractual Term Years161 To193 OutstandingOptionsWeightedAverageRemainingContractualTermYears161To193	P6Y9M10D
CY2022Q4	gdrzf	Exercisable Options Number161 To193 ExercisableOptionsNumber161To193	435000	shares
CY2022Q4	gdrzf	Exercisable Options Weighted Average Exercise Price177 ExercisableOptionsWeightedAverageExercisePrice177	1.77
CY2022Q4	gdrzf	Exercisable Options Weighted Average Exercise Price161 To193 ExercisableOptionsWeightedAverageExercisePrice161To193	0
CY2022	gdrzf	Exercisable Options Weighted Average Remaining Contractual Term Years161 To193 ExercisableOptionsWeightedAverageRemainingContractualTermYears161To193	P6Y9M10D
CY2022Q4	gdrzf	Outstanding Options Number239 OutstandingOptionsNumber239	3369643	shares
CY2022Q4	gdrzf	Outstanding Options Aggregate Intrinsic Value239 OutstandingOptionsAggregateIntrinsicValue239	0	usd
CY2022	gdrzf	Outstanding Options Weighted Average Remaining Contractual Term Years239 OutstandingOptionsWeightedAverageRemainingContractualTermYears239	P4Y1M17D
CY2022Q4	gdrzf	Exercisable Options Number239 ExercisableOptionsNumber239	3369643	shares
CY2022Q4	gdrzf	Exercisable Options Weighted Average Exercise Price239 ExercisableOptionsWeightedAverageExercisePrice239	2.39
CY2022Q4	gdrzf	Exercisable Options Aggregate Intrinsic Value239 ExercisableOptionsAggregateIntrinsicValue239	0	usd
CY2022	gdrzf	Exercisable Options Weighted Average Remaining Contractual Term Years239 ExercisableOptionsWeightedAverageRemainingContractualTermYears239	P4Y1M17D
CY2022Q4	gdrzf	Outstanding Options Number315 To326 OutstandingOptionsNumber315To326	430000	shares
CY2022Q4	gdrzf	Outstanding Options Aggregate Intrinsic Value315 To326 OutstandingOptionsAggregateIntrinsicValue315To326	0	usd
CY2022	gdrzf	Outstanding Options Weighted Average Remaining Contractual Term Years315 To326 OutstandingOptionsWeightedAverageRemainingContractualTermYears315To326	P1Y11M12D
CY2022Q4	gdrzf	Exercisable Options Number315 To326 ExercisableOptionsNumber315To326	430000	shares
CY2022Q4	gdrzf	Exercisable Options Weighted Average Exercise Price315 To326 ExercisableOptionsWeightedAverageExercisePrice315To326	3.21
CY2022Q4	gdrzf	Exercisable Options Aggregate Intrinsic Value315 To326 ExercisableOptionsAggregateIntrinsicValue315To326	0	usd
CY2022	gdrzf	Exercisable Options Weighted Average Remaining Contractual Term Years315 To326 ExercisableOptionsWeightedAverageRemainingContractualTermYears315To326	P1Y11M12D
CY2022Q4	gdrzf	Outstanding Options Number Total OutstandingOptionsNumberTotal	7578393	shares
CY2022Q4	gdrzf	Outstanding Options Aggregate Intrinsic Value Total OutstandingOptionsAggregateIntrinsicValueTotal	73250	usd
CY2022	gdrzf	Outstanding Options Weighted Average Remaining Contractual Term Years Total OutstandingOptionsWeightedAverageRemainingContractualTermYearsTotal	P6Y3M
CY2022Q4	gdrzf	Exercisable Options Number Total ExercisableOptionsNumberTotal	7578393	shares
CY2022Q4	gdrzf	Exercisable Options Weighted Average Exercise Price Total ExercisableOptionsWeightedAverageExercisePriceTotal	2.03
CY2022Q4	gdrzf	Exercisable Options Aggregate Intrinsic Value Total ExercisableOptionsAggregateIntrinsicValueTotal	73250	usd
CY2022	gdrzf	Exercisable Options Weighted Average Remaining Contractual Term Years Total ExercisableOptionsWeightedAverageRemainingContractualTermYearsTotal	P6Y3M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	360000	shares
CY2022	gdrzf	Option Expense OptionExpense	159218	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3000000.0	shares
CY2021Q4	gdrzf	Option Expense OptionExpense	1900000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3033750	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	260000	shares
CY2021	gdrzf	Option Expense OptionExpense	1992415	usd
CY2020	gdrzf	Option Expense OptionExpense	656775	usd
CY2021	gdrzf	Option Expense In Ga OptionExpenseInGA	1600000	usd
CY2021	gdrzf	Option Expense In Siembra Minera OptionExpenseInSiembraMinera	400000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.41
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.64
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.72
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0418	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0094	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0026	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y8M23D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.55	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.45	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.49	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	gdrzf	Amount Payable In Event Of Change Of Control AmountPayableInEventOfChangeOfControl	4900000	usd
CY2022Q4	gdrzf	Amount Payable In Event Of Milestone Achievement AmountPayableInEventOfMilestoneAchievement	2800000	usd
CY2022Q4	gdrzf	Severance Liability SeveranceLiability	500000	usd
CY2022	gdrzf	Income Tax Benefit Based On Canadian Tax Rates IncomeTaxBenefitBasedOnCanadianTaxRates	2149129	usd
CY2022	gdrzf	Income Tax Benefit Based On Canadian Tax Rates Percentage IncomeTaxBenefitBasedOnCanadianTaxRatesPercentage	0.25	pure
CY2021	gdrzf	Income Tax Benefit Based On Canadian Tax Rates IncomeTaxBenefitBasedOnCanadianTaxRates	2649198	usd
CY2021	gdrzf	Income Tax Benefit Based On Canadian Tax Rates Percentage IncomeTaxBenefitBasedOnCanadianTaxRatesPercentage	0.25	pure
CY2020	gdrzf	Income Tax Benefit Based On Canadian Tax Rates IncomeTaxBenefitBasedOnCanadianTaxRates	3151661	usd
CY2020	gdrzf	Income Tax Benefit Based On Canadian Tax Rates Percentage IncomeTaxBenefitBasedOnCanadianTaxRatesPercentage	0.25	pure
CY2022	gdrzf	Different Tax Rates On Foreign Subsidiaries DifferentTaxRatesOnForeignSubsidiaries	-285668	usd
CY2022	gdrzf	Different Tax Rates On Foreign Subsidiaries Percentage DifferentTaxRatesOnForeignSubsidiariesPercentage	-0.03	pure
CY2021	gdrzf	Different Tax Rates On Foreign Subsidiaries DifferentTaxRatesOnForeignSubsidiaries	-658471	usd
CY2021	gdrzf	Different Tax Rates On Foreign Subsidiaries Percentage DifferentTaxRatesOnForeignSubsidiariesPercentage	-0.06	pure
CY2020	gdrzf	Different Tax Rates On Foreign Subsidiaries DifferentTaxRatesOnForeignSubsidiaries	-382207	usd
CY2020	gdrzf	Different Tax Rates On Foreign Subsidiaries Percentage DifferentTaxRatesOnForeignSubsidiariesPercentage	-0.03	pure
CY2022	gdrzf	Nondeductible Expenses NondeductibleExpenses	-91510	usd
CY2022	gdrzf	Nondeductible Expenses Percentage NondeductibleExpensesPercentage	-0.01	pure
CY2021	gdrzf	Nondeductible Expenses NondeductibleExpenses	-419589	usd
CY2021	gdrzf	Nondeductible Expenses Percentage NondeductibleExpensesPercentage	-0.04	pure
CY2020	gdrzf	Nondeductible Expenses NondeductibleExpenses	-155633	usd
CY2020	gdrzf	Nondeductible Expenses Percentage NondeductibleExpensesPercentage	-0.01	pure
CY2022	gdrzf	Change In Valuation Allowance And Other ChangeInValuationAllowanceAndOther	-1771951	usd
CY2022	gdrzf	Change In Valuation Allowance And Other Percentage ChangeInValuationAllowanceAndOtherPercentage	-0.21	pure
CY2021	gdrzf	Change In Valuation Allowance And Other ChangeInValuationAllowanceAndOther	-1571138	usd
CY2021	gdrzf	Change In Valuation Allowance And Other Percentage ChangeInValuationAllowanceAndOtherPercentage	-0.15	pure
CY2020	gdrzf	Change In Valuation Allowance And Other ChangeInValuationAllowanceAndOther	-1524461	usd
CY2020	gdrzf	Change In Valuation Allowance And Other Percentage ChangeInValuationAllowanceAndOtherPercentage	-0.12	pure
CY2022	gdrzf	Income Tax Benefit IncomeTaxBenefit	0	usd
CY2022	gdrzf	Income Tax Benefit Percent IncomeTaxBenefitPercent	0	pure
CY2021	gdrzf	Income Tax Benefit IncomeTaxBenefit	0	usd
CY2021	gdrzf	Income Tax Benefit Percent IncomeTaxBenefitPercent	0	pure
CY2020	gdrzf	Income Tax Benefit IncomeTaxBenefit	1089360	usd
CY2020	gdrzf	Income Tax Benefit Percent IncomeTaxBenefitPercent	0.09	pure
CY2022	gdrzf	Income Tax Benefit Recorded By The Company IncomeTaxBenefitRecordedByTheCompany	0	usd
CY2020	gdrzf	Income Tax Benefit Recorded By The Company IncomeTaxBenefitRecordedByTheCompany	1100000	usd
CY2022Q4	gdrzf	The Companys Income Tax Receivable TheCompanysIncomeTaxReceivable	8100000	usd
CY2022Q2	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39298070	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40045479	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2129038	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2023434	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1672940	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1537637	usd
CY2022Q4	gdrzf	Deferred Income Tax Assets Gross DeferredIncomeTaxAssetsGross	43100048	usd
CY2021Q4	gdrzf	Deferred Income Tax Assets Gross DeferredIncomeTaxAssetsGross	43606550	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43090943	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	43557562	usd
CY2022Q4	gdrzf	Deferred Income Tax Assets Net Of Valuation Allowance DeferredIncomeTaxAssetsNetOfValuationAllowance	9105	usd
CY2021Q4	gdrzf	Deferred Income Tax Assets Net Of Valuation Allowance DeferredIncomeTaxAssetsNetOfValuationAllowance	48988	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-9105	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-48988	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2026 CanadianTaxLossCarryforwardExpiring2026	1931223	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2027 CanadianTaxLossCarryforwardExpiring2027	3584098	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2028 CanadianTaxLossCarryforwardExpiring2028	13660950	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2029 CanadianTaxLossCarryforwardExpiring2029	12946583	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2030 CanadianTaxLossCarryforwardExpiring2030	15994783	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2031 CanadianTaxLossCarryforwardExpiring2031	17910454	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2032 CanadianTaxLossCarryforwardExpiring2032	5196582	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2033 CanadianTaxLossCarryforwardExpiring2033	7554761	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2034 CanadianTaxLossCarryforwardExpiring2034	8753336	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2035 CanadianTaxLossCarryforwardExpiring2035	12494741	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2036 CanadianTaxLossCarryforwardExpiring2036	14854933	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2037 CanadianTaxLossCarryforwardExpiring2037	11202657	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2038 CanadianTaxLossCarryforwardExpiring2038	1072063	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2039 CanadianTaxLossCarryforwardExpiring2039	2794104	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2040 CanadianTaxLossCarryforwardExpiring2040	4153315	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2041 CanadianTaxLossCarryforwardExpiring2041	15034518	usd
CY2022Q4	gdrzf	Canadian Tax Loss Carryforward Expiring2042 CanadianTaxLossCarryforwardExpiring2042	3958003	usd
CY2022Q4	gdrzf	Us Tax Loss Carryforward UsTaxLossCarryforward	4875207	usd
CY2022Q4	gdrzf	Total Us Tax Loss Carryforward TotalUsTaxLossCarryforward	4875207	usd
CY2022Q4	gdrzf	Total Canadian Tax Loss Carryforward TotalCanadianTaxLossCarryforward	153097104	usd

Files In Submission

Name	View Source	Status
0001072725-23-000009-index-headers.html	Edgar Link	pending
0001072725-23-000009-index.html	Edgar Link	pending
0001072725-23-000009.txt	Edgar Link	pending
0001072725-23-000009-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gdrzf-20221231.xsd	Edgar Link	pending
gdrzfform20f042723.htm	Edgar Link	pending
gdrzfform20fex121042723.htm	Edgar Link	pending
gdrzfform20fex122042723.htm	Edgar Link	pending
gdrzfform20fex131042723.htm	Edgar Link	pending
gdrzfform20fex132042723.htm	Edgar Link	pending
gdrzfform20fex151042723.htm	Edgar Link	pending
gdrzfform20fex42042723.htm	Edgar Link	pending
gdrzfform20fex80042723.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
gdrzf-20221231_cal.xml	Edgar Link	unprocessable
gdrzf-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
gdrzf-20221231_pre.xml	Edgar Link	unprocessable
gdrzf-20221231_lab.xml	Edgar Link	unprocessable
gdrzfform20f042723_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GDRZF
GOLD RESERVE LTD Stock $gdrzf

2022 Q4 Form 20-F Financial Statement

#000107272523000009 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GDRZF GOLD RESERVE LTD Stock $gdrzf

2022 Q4 Form 20-F Financial Statement

#000107272523000009 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GDRZF
GOLD RESERVE LTD Stock $gdrzf